Bausch Health Companies Inc.
BHC.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.23B | 2.53B | 2.48B | 2.38B | 2.13B |
| Total Other Revenue | 32.00M | 31.00M | 28.00M | 24.00M | 24.00M |
| Total Revenue | 2.26B | 2.56B | 2.51B | 2.40B | 2.15B |
| Cost of Revenue | 701.00M | 727.00M | 696.00M | 719.00M | 640.00M |
| Gross Profit | 1.56B | 1.83B | 1.81B | 1.68B | 1.51B |
| SG&A Expenses | 862.00M | 816.00M | 850.00M | 832.00M | 789.00M |
| Depreciation & Amortization | 256.00M | 259.00M | 274.00M | 270.00M | 274.00M |
| Other Operating Expenses | 28.00M | -- | -- | 3.00M | -- |
| Total Operating Expenses | 1.99B | 1.97B | 1.97B | 1.98B | 1.85B |
| Operating Income | 269.00M | 594.00M | 544.00M | 423.00M | 299.00M |
| Income Before Tax | -47.00M | 209.00M | -21.00M | 48.00M | -69.00M |
| Income Tax Expenses | 39.00M | 111.00M | 71.00M | 49.00M | 8.00M |
| Earnings from Continuing Operations | -86.00M | 98.00M | -92.00M | -1.00M | -77.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 28.00M | -5.00M | 7.00M | 11.00M | 13.00M |
| Net Income | -58.00M | 93.00M | -85.00M | 10.00M | -64.00M |
| EBIT | 269.00M | 594.00M | 544.00M | 423.00M | 299.00M |
| EBITDA | 574.00M | 901.00M | 866.00M | 741.00M | 619.00M |
| EPS Basic | -0.16 | 0.25 | -0.23 | 0.03 | -0.17 |
| Normalized Basic EPS | -0.02 | 0.40 | 0.37 | 0.15 | -0.07 |
| EPS Diluted | -0.16 | 0.25 | -0.23 | 0.03 | -0.17 |
| Normalized Diluted EPS | -0.02 | 0.40 | 0.37 | 0.15 | -0.07 |
| Average Basic Shares Outstanding | 369.60M | 372.00M | 368.40M | 367.90M | 366.80M |
| Average Diluted Shares Outstanding | 369.60M | 372.00M | 368.40M | 370.20M | 366.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |